DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

E7107

Generic Name: E7107

Drug Type: Small Molecule

Chemical Formula: C_₄₀H_₆₆N_₂O_₉

CAS Number: 630100-90-2

Unique Ingredient Identifier: R60DZX1E2N

Overview

E7107 has been used in trials studying the treatment of Cancer.

Background

E7107 has been used in trials studying the treatment of Cancer.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Dose Escalation Study of E7107 Administered Intravenously on Days 1 and 8 Every 21 Days to Patients With Solid Tumors

Phase 1

Suspended

Posted: 2007/07/11

Sponsor:Eisai Inc.

A Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With Solid Tumours

Phase 1

Suspended

Posted: 2007/04/13

Sponsor:Eisai Limited

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy